Chris Fourment

Real-World Prescribing Patterns of Certolizumab in the Treatment of Crohn’s Disease

BACKGROUND: Certolizumab (CZP) is a pegylated anti-tumor necrosis factor (TNF) agent approved for the treatment of moderate-to-severe Crohn’s disease (CD). CZP therapy has proven effectiv...

Timothy Ritter ;

Chris Fourment ;

Samantha Kuten ;

Lucinda J. Van Anglen ;

12/12/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Chris Fourment

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products